Clinical Trials Directory

Trials / Completed

CompletedNCT05231915

Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
465 (actual)
Sponsor
University Hospital Center of Martinique · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

In Martinique, prostate cancer incidence rates are nowadays among the highest worldwide with a high incidence of early-onset and familial forms. We identified a rare heterozygous germline variant c.853delT (p.Ter285Lysfs) rs77179853, reported only among patients of African ancestry with a minor allele frequency of 3.2%. We search to estimate the prevalence of this variant in a sample of prevalent prostate cancer cases managed in urology consultation in Martinique .

Detailed description

In Martinique, prostate cancer incidence rates are nowadays among the highest worldwide with a high incidence of early-onset and familial forms. Despite the demonstration of a strong familial component, identification of the genetic basis for hereditary prostate cancer is challenging. The screening of the HOXB13 gene is recommended for men who develop an early-onset and/or familial Pca . In fact, the HOXB13 germline variant G84E (rs138213197) was described in men of European descent with prostate cancer risk. Other germline variants were detected in ethnic groups. More recently, we reported a rare HOXB13 mutation, specifically c.853delT (pTer285Lysfs) that appears to be contribute to young Prostate Cancer cases in Martinique. This variant is a stop loss reported only among patients of African ancestry . Regarding the allele frequency of the HOXB13 c.853delT variant observed in the Pca cohort, it will be necessary to assess relative and absolute Pca risks for HOXB13 c.853delT carriers. This information is essential to use this variant in genetic counseling. We propose to sequence the HOXB13 gene of all prostate cancers cases managed in urology consultation in Martinique.

Conditions

Interventions

TypeNameDescription
GENETICHOXB13 c.853delT mutationIdentify the Allelic frequency of the HOXB13 c.853delT mutation in patients with a cancer prostate in Martinique

Timeline

Start date
2021-04-09
Primary completion
2024-11-27
Completion
2025-03-09
First posted
2022-02-09
Last updated
2026-03-31

Locations

1 site across 1 country: Martinique

Source: ClinicalTrials.gov record NCT05231915. Inclusion in this directory is not an endorsement.